(PharmaNewsWire.Com, September 20, 2017 ) Scope of the Report The report titled "Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)", provides an in-depth analysis of the global CGM market. The report also gives an insight of the global CGM market by value, by penetration, by products, by components, by region, etc.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CGM market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in global CGM market is dominated by the two big players, DexCom Incorporation and Medtronic. Further, key players of the CGM market DexCom, Incorporation, Medtronic and Abbott Laboratories are also profiled with their financial information and respective business strategies.
Continuous Glucose Monitoring (CGM) is a small glucose sensor (electrodes) inserted under the skin that keeps in check the glucose levels in interstitial fluid. The sensor stays in body for several days to a week before being replaced. A transmitter that is placed on the body sends information about the level of glucose via radio waves from the sensor to a wireless monitor that could be in the form of a wristband or it could be an app on the smartphone that allows the patient to view their glucose measurements. The CGM system basically has been designed to target the type1 diabetic population, for the early detection of hypo and hyperglycemia. The CGM system is made of three parts: a wireless monitor (receiver), a transmitter and a sensor. The CGM market has several advantages and disadvantages.
Global CGM market has increased at a significant CAGR during the years 2014-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The CGM market is expected to increase due to increasing population with type1 diabetes, sedentary lifestyle, rising population with obesity, etc. Yet, the market faces some challenges such as, intense competition in the market, lack of penetration in type 2 diabetes, lack of reliability and accuracy in data.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
